TABLE 2.
Drug release models for the in vitro release study.
| Formulation | Drug release models (R2) | ||||
|---|---|---|---|---|---|
| Zero order | First order | Higuchi | Hixon–Crowell | Korsmeyer–Peppas | |
| CA-NLC | 0.6113 | 0.4573 | 0.8117 | 0.7337 | 0.8677 |
| CA-NLC-gel | 0.768 | 0.386 | 0.925 | 0.845 | 0.936 |
| SA-NLC | 0.6544 | 0.4981 | 0.8478 | 0.7619 | 0.949 |
| SA-NLC-gel | 0.6501 | 0.4217 | 0.8432 | 0.7186 | 0.8939 |
| GMS-NLC | 0.6875 | 0.5313 | 0.8736 | 0.784 | 0.962 |
| GMS-NLC-gel | 0.7031 | 0.4658 | 0.8829 | 0.7629 | 0.9109 |
| Mkt-gel | 0.9073 | 0.5586 | 0.9887 | 0.936 | 0.9608 |